Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Psychiatry Reports
Erschienen in: Current Psychiatry Reports 8/2019

01.08.2019 | Anxiety Disorders (A Pelissolo, Section Editor)

Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature

verfasst von: Chloé Tezenas du Montcel, Antoine Pelissolo, Franck Schürhoff, Baptiste Pignon

Erschienen in: Current Psychiatry Reports | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review will aim to summarize the current body of epidemiological, clinical and therapeutic knowledge concerning specific co-occurrence of obsessive-compulsive symptoms (OCSs) and schizophrenia spectrum disorder.

Recent Findings

Almost 30% of the patients with schizophrenia display OCS, and three main contexts of emergence are identified: prodromal symptoms of schizophrenia, co-occurrence of OCS and schizophrenia and antipsychotics-induced OCS. Recent clinical studies show that patients with SZ and OCS have more severe psychotic and depressive symptoms, higher suicidality and lower social functioning. A recent cognitive investigation found that OCS and delusions share specific metacognitive profiles, particularly through a heightened need to control thoughts. Finally, a recent cross-sectional study of clozapine-induced OCS found a dose-response relationship between clozapine and OCS.

Summary

OCS appeared reliably as linked to poorer outcomes among patients with schizophrenia. However, the specific clinical value of OCS among other prodromal symptoms of schizophrenia remains unknown.
Literatur
1.
Kelly JR, Clarke G, Cryan JF, Dinan TG. Dimensional thinking in psychiatry in the era of the research domain criteria (RDoC). Ir J Psychol Med. 2018;35:89–94.CrossRef
2.
Leboyer M, Schurhoff F. Searching across diagnostic boundaries. Schizophr Bull. 2014;40:946–8.CrossRef
3.
Westphal K. Über Zwangsvorstellungen. Archiv fur Psychiatr und Nervenkr. 1878;8:734–750.
4.
Bleuler M, Bleuler R. Dementia praecox oder die Gruppe der Schizophrenien: Eugen Bleuler. Br J Psychiatry. 1986;149:661–4.CrossRef
5.
Janet P, Raymond F. Les obsessions et la psychasténie. Vol. 2. Paris: Felix Alcan; 1903.
6.
Attademo L, Bernardini F, Paolini E, Quartesan R. History and conceptual problems of the relationship between obsessions and hallucinations. Harv Rev Psychiatry. 2015;23:19–27.CrossRef
7.
Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy M-A. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011;37:811–21.CrossRef
8.
Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30:327–37.CrossRef
9.
Swets M, Dekker J, van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L, et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res. 2014;152:458–68.CrossRef
10.
Attademo L, De Giorgio G, Quartesan R, Moretti P. Schizophrenia and obsessive-compulsive disorder: from comorbidity to schizo-obsessive disorder. Riv Psichiatr. 2012;47:106–15.PubMed
11.
Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci JPN. 2005;30:187–93.PubMed
12.
Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia. CNS Drugs. 2004;18:989–1010.CrossRef
13.
Cederlöf M, Lichtenstein P, Larsson H, Boman M, Rück C, Landén M, et al. Obsessive-compulsive disorder, psychosis, and bipolarity: a longitudinal cohort and multigenerational family study. Schizophr Bull. 2015;41:1076–83.CrossRef
14.
Van Dael F, van Os J, de Graaf R, ten Have M, Krabbendam L, Myin-Germeys I. Can obsessions drive you mad? Longitudinal evidence that obsessive-compulsive symptoms worsen the outcome of early psychotic experiences. Acta Psychiatr Scand. 2011;123:136–46.CrossRef
15.
Meier SM, Petersen L, Pedersen MG, Arendt MCB, Nielsen PR, Mattheisen M, et al. Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatry. 2014;71:1215–21.CrossRef
16.
Nelson B, Yuen K, Yung AR. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Schizophr Res. 2011;125:62–8.CrossRef
17.
Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, et al. Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry. 2016;73:113–20.CrossRef
18.
Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39:964–71.CrossRef
19.
Fontenelle LF, Lin A, Pantelis C, Wood SJ, Nelson B, Yung AR. A longitudinal study of obsessive-compulsive disorder in individuals at ultra-high risk for psychosis. J Psychiatr Res. 2011;45:1140–5.CrossRef
20.
Łucka I, Fryze M, Cebella A, Staszewska E. Prodromal symptoms of schizophrenics syndrome in children and adolescent. Psychiatr Pol. 2002;36:283–6.PubMed
21.
Poyurovsky M, Zohar J, Glick I, Koran LM, Weizman R, Tandon R, et al. Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications. Compr Psychiatry. 2012;53:480–3.CrossRef
22.
Niendam TA, Berzak J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res. 2009;108:170–5.CrossRef
23.
de Haan L, Sterk B, Wouters L, Linszen DH. The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull. 2013;39:151–60.CrossRef
24.
Hagen K, Hansen B, Joa I, Larsen TK. Prevalence and clinical characteristics of patients with obsessive-compulsive disorder in first-episode psychosis. BMC Psychiatry. 2013;13:156.CrossRef
25.
Poyurovsky M, Faragian S, Kleinman-Balush V, Pashinian A, Kurs R, Fuchs C. Awareness of illness and insight into obsessive-compulsive symptoms in schizophrenia patients with obsessive-compulsive disorder. J Nerv Ment Dis. 2007;195:765–8.CrossRef
26.
Jacob ML, Larson MJ, Storch EA. Insight in adults with obsessive-compulsive disorder. Compr Psychiatry. 2014;55:896–903.CrossRef
27.
Cherian AV, Narayanaswamy JC, Srinivasaraju R, Viswanath B, Math SB, Kandavel T, et al. Does insight have specific correlation with symptom dimensions in OCD? J Affect Disord. 2012;138:352–9.CrossRef
28.
Catapano F, Perris F, Fabrazzo M, Cioffi V, Giacco D, De Santis V, et al. Obsessive-compulsive disorder with poor insight: a three-year prospective study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34:323–30.CrossRef
29.
Fontenelle JM, Harrison BJ, Santana L, Conceição do Rosário M, Versiani M, Fontenelle LF. Correlates of insight into different symptom dimensions in obsessive-compulsive disorder. Ann Clin Psychiatry. 2013;25:11–6.PubMed
30.
Oulis P, Konstantakopoulos G, Lykouras L, Michalopoulou PG. Differential diagnosis of obsessive-compulsive symptoms from delusions in schizophrenia: a phenomenological approach. World J Psychiatry. 2013;3:50–6.CrossRef
31.
Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2005;8:107–29.CrossRef
32.
Cunill R, Castells X, Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry. 2009;70:70–82.CrossRef
33.
• Baytunca B, Kalyoncu T, Ozel I, Erermiş S, Kayahan B, Öngur D. Early onset schizophrenia associated with obsessive-compulsive disorder: clinical features and correlates. Clin Neuropharmacol. 2017;40:243–5. In a retrospective chart review of 29 patients with early onset SZ (10 with OCS/SZ, 19 SZ), patients suffering from SZ/OCS received significantly higher doses of antipsychotics during the first episode and at assessment (no sociodemographic differences, similar duration of illnesses and had comparable severity scores on PANSS). CrossRef
34.
• Tonna M, Ottoni R, Paglia F, Monici A, Ossola P, DE Panfilis C, et al. Obsessive-compulsive symptoms in schizophrenia and in obsessive-compulsive disorder: differences and similarities. J Psychiatr Pract. 2016;22:111–6. In this clinical study of the content of obsessions and compulsions in 66 patients suffering from SZ/OCD (n= 35) or OCD (n=31), OCD patients had a greater level of distress for obsession and compulsion, and obsessive ideas were more aggressive, contamination-related, sexual and somatic obsession in the OCD group than in the SZ group. Patients had similar severity levels, and no association were found between OCS severity and PANSS scores, but delusional symptoms were positively associated with the presence of washing compulsion and hoarding obsession. CrossRef
35.
Szmulewicz AG, Smith JM, Valerio MP. Suicidality in clozapine-treated patients with schizophrenia: role of obsessive-compulsive symptoms. Psychiatry Res. 2015;230:50–5.CrossRef
36.
Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992;6:201–8.CrossRef
37.
Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437–41.CrossRef
38.
Hur J-W, Shin NY, Jang JH, Shim G, Park HY, Hwang JY, et al. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms. Aust N Z J Psychiatry. 2012;46:161–9.CrossRef
39.
Marder SR, Fenton W. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res. 2004;72:5–9.CrossRef
40.
Bulzacka E, Boyer L, Schürhoff F, Godin O, Berna F, Brunel L, et al. Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset. Schizophr Bull. 2016;42:1290–302.CrossRef
41.
Roux P, Urbach M, Fonteneau S, Berna F, Brunel L, Capdevielle D, et al. Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the evaluation of cognitive processes involved in disability in schizophrenia (ECPDS) scale. Schizophr Res. 2018;201:196–203.CrossRef
42.
Michalopoulou PG, Konstantakopoulos G, Typaldou M, Papageorgiou C, Christodoulou GN, Lykouras L, et al. Can cognitive deficits differentiate between schizophrenia with and without obsessive-compulsive symptoms? Compr Psychiatry. 2014;55:1015–21.CrossRef
43.
•• Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, et al. Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study. Schizophr Bull. 2013;39:1261–71. In this 6-months longitudinal study of SZ patients (N = 56) and their unaffected siblings (N = 49), higher severity of positive, negative, and depressive symptoms was positively associated with higher concurrent OCS severity across subject and significantly predicted OCS severity 4 weeks later and vice-versa. CrossRef
44.
Pallanti S, Castellini G, Chamberlain SR, Quercioli L, Zaccara G, Fineberg NA. Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms. Psychiatry Res. 2009;170:52–60.CrossRef
45.
•• Hagen K, Solem S, Opstad HB, Hansen B, Hagen R. The role of metacognition and obsessive-compulsive symptoms in psychosis: an analogue study. BMC Psychiatry. 2017;17:233. Among a non-clinical sample (N = 194), OCS were moderately-strongly correlated with psychotic symptoms (paranoia and hallucinations). OCS and metacognitive dysfunction both showed a significant influence and accounted for important variance on the levels of paranoid ideation and hallucinations. CrossRef
46.
Morrison AP, Haddock G, Tarrier N. Intrusive thoughts and auditory hallucinations: a cognitive approach. Behav Cogn Psychother. 1995;23:265–80.CrossRef
47.
Moritz S, Peters MJV, Larøi F, Lincoln TM. Metacognitive beliefs in obsessive-compulsive patients: a comparison with healthy and schizophrenia participants. Cogn Neuropsychiatry. 2010;15:531–48.CrossRef
48.
de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 1999;60:364–365.CrossRef
49.
Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439–42.PubMed
50.
Grillault Laroche D, Gaillard A. Induced obsessive compulsive symptoms (OCS) in schizophrenia patients under atypical 2 antipsychotics (AAPs): review and hypotheses. Psychiatry Res. 2016;246:119–28.CrossRef
51.
Fonseka TM, Richter MA, Müller DJ. Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature. Curr Psychiatry Rep. 2014;16:510.CrossRef
52.
Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: insight into pathomechanisms facilitates treatment. Adv Med. 2014;2014:317980.CrossRef
53.
Schirmbeck F, Konijn M, Hoetjes V, Zink M, de Haan L. For genetic risk and outcome of psychosis (GROUP). Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels. Eur Arch Psychiatry Clin Neurosci. 2018.
54.
Lin S-K, Su S-F, Pan C-H. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms. Ther Drug Monit. 2006;28:303–7.CrossRef
55.
Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology. 1989;99(Suppl):S18–27.CrossRef
56.
Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, et al. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole. Clin Neuropharmacol. 2009;32:227–9.CrossRef
57.
Englisch S, Zink M. Combined antipsychotic treatment involving clozapine and aripiprazole. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32:1386–92.CrossRef
58.
•• Fernandez-Egea E, Worbe Y, Bernardo M, Robbins TW. Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia. Psychol Med. 2018;48:2668–75. In this study of risk factor of clozapine-induced OCS in a sample of clozapine-treated SZ patients (N = 118), 47 % of the sample reached threshold criteria for OCD and were on anti-OCD medication. Length of clozapine treatment was correlated with checking severity and authors showed a direct correlation between OCS and clozapine plasma levels. Patients on polypharmacy had higher OCS scores and higher OCD prevalence. CrossRef
59.
Schirmbeck F, Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol. 2013;4:99.CrossRef
60.
Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med. 2011;41:2361–73.CrossRef
61.
Stryjer R, Dambinsky Y, Timinsky I, Green T, Kotler M, Weizman A, et al. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study. Int Clin Psychopharmacol. 2013;28:96–8.CrossRef
62.
Poyurovsky M, Faragian S, Shabeta A, Kosov A. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder. Psychiatry Res. 2008;159:133–9.CrossRef
63.
Sugarman MA, Kirsch I, Huppert JD. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: a meta-analysis. J Affect Disord. 2017;218:217–26.CrossRef
64.
Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry. 2004;65(Suppl 14):11–7.PubMed
65.
Pignon B, Tezenas du Montcel C, Carton L, Pelissolo A. The place of antipsychotics in the therapy of anxiety disorders and obsessive-compulsive disorders. Curr Psychiatry Rep. 2017;19:103.CrossRef
66.
van Nimwegen L, de Haan L, van Beveren N, Laan W, van den Brink W, Linszen D. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. J Clin Psychopharmacol. 2008;28:214–8.CrossRef
67.
Temmingh H, Stein DJ. Anxiety in patients with schizophrenia: epidemiology and management. CNS Drugs. 2015;29:819–32.CrossRef
68.
McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry. 1994;55(Suppl):24–31.PubMed
69.
Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2009;70:863–8.CrossRef
70.
Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999;156:286–93.PubMed
71.
Ramasubbu R, Ravindran A, Lapierre Y. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry. 2000;33:236–8.CrossRef
72.
73.
Villari V, Frieri T, Fagiolini A. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms. J Clin Psychopharmacol. 2011;31:375–6.CrossRef
74.
Eryılmaz G, Hızlı Sayar G, Ozten E, Gögcegöz Gül I, Karamustafalıoğlu O. Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia. Ann General Psychiatry. 2013;12:40.CrossRef
75.
Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:423–9.PubMed
76.
Hanisch F, Friedemann J, Piro J, Gutmann P. Maintenance electroconvulsive therapy for comorbid pharmacotherapy-refractory obsessive-compulsive and schizoaffective disorder. Eur J Med Res. 2009;14:367–8.CrossRef
77.
Tundo A, Necci R. Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis: systematic review of evidence. World J Psychiatry. 2016;6:449–55.CrossRef
Metadaten
Titel
Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature
verfasst von
Chloé Tezenas du Montcel
Antoine Pelissolo
Franck Schürhoff
Baptiste Pignon
Publikationsdatum
01.08.2019
Verlag
Springer US
Erschienen in
Current Psychiatry Reports / Ausgabe 8/2019
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-019-1051-y

Weitere Artikel der Ausgabe 8/2019

Current Psychiatry Reports 8/2019 Zur Ausgabe

Schizophrenia and Other Psychotic Disorders (AK Pandurangi, Section Editor)

Neuroinflammation and Schizophrenia

Psychiatry in the Digital Age (J Shore, Section Editor)

Without Wasting a Word: Extreme Improvements in Efficiency and Accuracy Using Computerized Adaptive Testing for Mental Health Disorders (CAT-MH)

Psychiatry in the Digital Age (J Shore, Section Editor)

Digital Health Solutions for Indigenous Mental Well-Being

Psychiatry in the Digital Age (J Shore, Section Editor)

Best Practices in Tele-Teaming: Managing Virtual Teams in the Delivery of Care in Telepsychiatry

Child and Family Disaster Psychiatry (B Pfefferbaum, Section Editor)

Continuous Traumatic Stress and the Life Cycle: Exposure to Repeated Political Violence in Israel

Bipolar Disorders (R Hirschfeld, Section Editor)

120th Anniversary of the Kraepelinian Dichotomy of Psychiatric Disorders

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Depression antepartal oder postpartal | Nachrichten

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein
weitere anzeigen

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen